Clinical Trials Browser

Not yet recruiting × Interventional × Polycythemia Vera × Clear all

Polycythemia Vera, Primary Myelofibrosis

NCT07518940 2026-04-09

ENERGIA

Motor Activity, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis

NCT07445893 2026-03-03

A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV

Phase NA Not yet recruiting

30 enrolled

Myeloid

Polycythemia Vera

NCT07429266 2026-02-24

A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

Phase 3 Not yet recruiting

250 enrolled

Myeloid

Polycythemia Vera

NCT07349134 2026-01-20

WELL-MPN

Phase NA Not yet recruiting

75 enrolled

Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT07341048 2026-01-15

ACTIVAQ

Phase NA Not yet recruiting

54 enrolled

Myeloid

Polycythemia, Polycythemia Vera

NCT06290765 2025-07-31

PV

Phase 4 Not yet recruiting

70 enrolled

Myeloid

Myeloproliferative Disorders, Polycythemia Vera

NCT07012109 2025-06-10

Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV)

Phase 1 Not yet recruiting

90 enrolled

Myeloid

Polycythemia Vera

NCT06923670 2025-05-15

Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History

Phase NA Not yet recruiting

496 enrolled

Myeloid

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Clinical Trials

Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers

ENERGIA

A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV

A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

WELL-MPN

ACTIVAQ

PV

Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV)

Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History